Patent Valuation

Nortel Networks → Rockstar Consortium (2011)

Apple, Microsoft, RIM, Ericsson, and Sony formed Rockstar to win this auction over Google. Patents covered wireless, semiconductors, and networking.

Kodak Patents → Various buyers (2012–2013)

Auctioned in Kodak's bankruptcy. Apple, Google, and others acquired the core digital camera and sharing patents.

InterDigital patent portfolio sales (ongoing)

InterDigital regularly monetizes wireless SEPs. High per-patent value reflects attached licensing revenue streams.

Typical NPE single-patent transaction

Price depends on identified infringers, claim quality, remaining term, and litigation history. Battle-tested patents (survived IPR) command significant premiums.

Pharmaceuticals / Biotech

2–15%

Higher for breakthrough drugs; lower for generics

Medical Devices

3–10%

Net sales; higher for implantable devices

Semiconductors / Electronics

0.5–5%

Often per-unit or % of chip price

Software / SaaS

2–10%

Often % of subscription revenue

Consumer Products

3–8%

Retail price basis

Automotive

0.5–3%

Component value, not vehicle price

Telecom / Wireless (SEPs)

0.1–2%

Per device; stacking concerns limit individual rates

Mechanical / Industrial

1–5%

Manufacturing cost basis

What are the three methods for valuing a patent?

The three standard approaches to patent valuation are: (1) Cost approach — calculates the total cost to develop, file, prosecute, and maintain the patent (R&D costs, attorney fees, filing fees, maintenance fees). This sets a floor — the patent should be worth at least what it cost to create. Used for insurance and balance sheet purposes, but rarely reflects market value. (2) Market approach — identifies comparable patent transactions (sales, licenses, litigation settlements) to benchmark value. Royalty rate databases (RoyaltySource, ktMINE, Licensing Executives Society surveys) provide market-based royalty rates by industry and technology sector. (3) Income approach — projects the future cash flows the patent will generate (licensing royalties, design-around avoidance savings, litigation settlement values) and discounts them to present value. This is the most theoretically sound method but requires significant assumptions about market size, royalty rates, remaining patent term, and probability of enforcement success.

What factors make a patent more valuable?

Key factors that increase patent value: (1) Broad independent claims — claims that cover the entire product category, not just the inventor's specific implementation; (2) Remaining term — more years until expiration means more years of exclusivity; (3) Technology adoption — the more widely the claimed technology is used, the more valuable the patent; (4) Difficulty to design around — patents where the competing product must use the claimed approach to function effectively are more valuable; (5) Clear written description — a specification that clearly supports the claims avoids enablement and written description attacks; (6) Prosecution history — clean prosecution without extensive claim narrowing; (7) Forward citation count — heavily cited patents tend to be technically important; (8) Active enforcement history — patents that have survived IPR challenges or litigation tend to command higher prices.

What is a reasonable royalty rate for a patent license?

Reasonable royalty rates vary enormously by industry and technology type. Typical ranges by sector: pharmaceuticals and biotech: 2–15% of net sales; semiconductor and electronics: 0.5–5% of net sales; software and SaaS: 2–10% of revenue; automotive technology: 0.5–3% of component value; consumer products: 3–8% of net sales; medical devices: 3–10% of net sales. These are rough ranges — actual rates depend on the Georgia-Pacific factors, the importance of the patent to the product, whether the patent is the only one covering the feature or one of many, remaining term, and field-of-use restrictions. The smallest salable patent-practicing unit (SSPPU) methodology typically yields lower rates than end-product royalties.

How much do patents sell for in NPE and portfolio transactions?

Single patents in litigation-quality transactions typically sell for $200,000–$2,000,000 depending on the technology sector, claim quality, remaining term, and presence of identified infringers. Patents covering widely-deployed technology in cellular (5G/LTE), Wi-Fi, or video codec standards can sell for $5,000,000–$50,000,000 or more in portfolio blocks. In corporate M&A, patent portfolios are rarely valued independently — they are part of the overall business valuation. When patent portfolios transfer in pure IP transactions (e.g., Nortel patent auction in 2011, which sold 6,000+ patents for $4.5B, or Kodak's patent portfolio in 2012 for $525M), the per-patent average price can be calculated but varies wildly by the strategic value of the specific claims to specific buyers.

How do venture capital investors value a startup's patent portfolio?

VC investors rarely perform independent patent valuation — they assess patents as a signal of competitive moat and defensibility. Key things investors look at: (1) Are the patents issued or pending? Issued patents are defensible; applications are just applications. (2) Do the claims cover what the company actually does, or are they a product of narrow prosecution? (3) Does the company own the patents (proper assignment from founders and employees)? (4) Are there any encumbrances (security interests, licensing commitments)? (5) Is the patent portfolio building — is the company continuing to file? (6) Does the portfolio signal R&D investment and deep technical knowledge? For most early-stage investments, patents are a qualitative signal, not a DCF input. Strategic acquirers (not VCs) are the ones who will do detailed patent valuation during due diligence.